Scarica l'app Stockscreener
0.8517
7.25%
-0.0666
Dopo l'orario di chiusura:
.80
-0.0517
-6.07%
Arcadia Biosciences Inc Borsa (RKDA) Ultime notizie
Arcadia Biosciences Announces $4 Million Private Placement - TipRanks
Arcadia Biosciences Raises ~$4 Million in Private Placement of Pre-Funded Warrants and Options - TradingView
Arcadia Biosciences (RKDA) completes $4M private placement with warrants and options - Stock Titan
RKDA Q3 2025 Earnings: Surprise Profit Beats Estimates by Wide MarginDownward Estimate Revision - newsline.com
Arcadia Biosciences closes $4 million private placement - Investing.com
Arcadia Biosciences closes $4 million private placement By Investing.com - Investing.com South Africa
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - The Manila Times
Arcadia Biosciences, Inc. Closes $4 Million Private Placement of Common Stock and Preferred Investment Options - Quiver Quantitative
Arcadia Biosciences raises $4M in at-the-market stock deal - Stock Titan
Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced ... - Caledonian Record
Arcadia Biosciences (RKDA) Announces Closing of $4 Million - GlobeNewswire
MSN Money - MSN
RKDA News | ARCADIA BIOSCIENCES INC (NASDAQ:RKDA) - ChartMill
Arcadia Biosciences Raises $4 Million in Private Placement - marketscreener.com
What Does Arcadia Biosciences' Latest $4 Million Private Placement Entail - Kavout
Wellness products maker Arcadia Biosciences lines up $4M in funding - Stock Titan
Arcadia Biosciences (RKDA) Secures Funding with New Share Agreem - GuruFocus
Arcadia Biosciences, Inc. Announces Private Placement of Common Stock and Preferred Investment Options to Raise Approximately $4 Million - Quiver Quantitative
Arcadia Biosciences raises $4 million in private placement - Investing.com
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under ... - Caledonian Record
Arcadia Biosciences (RKDA) Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - GlobeNewswire Inc.
Arcadia Biosciences, Inc. announced that it has received $3.999613 million in funding - marketscreener.com
Arcadia Biosciences (RKDA) jumps 44.5% amid heavy volume, with no clear new headline catalyst - Quiver Quantitative
RKDA Stock Whipsaws As Traders Focus On Cash, Chart - StocksToTrade
RKDA Stock Slides As Volatile Chart Tests Day Traders - timothysykes.com
RKDA Q3 2025 Earnings: EPS Surge Beats Estimates Amid No Revenue DisclosureEarnings Volatility Report - newsline.com
Arcadia Biosciences (RKDA) Slips 1.89% as Stock Tests Key Support Near $0.86Golden Cross - newsline.com
RKDA Q3 2025 Earnings: Positive EPS Surprise Amidst Revenue ChallengesCore Business Growth - newsline.com
RKDA Stock Price, Quote & Chart - ChartMill
RKDA Q3 2025 Earnings: Surprise Profitability Without Reported RevenueEarnings Revision Upgrade - newsline.com
Arcadia Biosciences (RKDA) Slides to $0.95: Support Test on the HorizonIV Percentile - newsline.com
Arcadia Biosciences Stock Under $1: Why RKDA’s Next Move Hinges on Zola and Cash - Bez Kabli
Arcadia Biosciences (RKDA) Shows Modest Uptick Amid Consolidation Near Key LevelsChange of Character - newsline.com
Arcadia Biosciences (RKDA) Q3 2025 Profit Surges Past Wall Street TargetsFinancial Health Score - The Legal Advocate
RKDA Q3 2025 Earnings: Stunning EPS Surprise Driven by Non-Recurring Items, Stock RalliesProduct Revenue Analysis - newsline.com
RKDA Q3 2025 Earnings: Arcadia Biosciences Posts Surprise Profit as EPS Smashes EstimatesRising Community Picks - Newser
RKDA Stock Pops On Volume As Traders Hunt Volatility - StocksToTrade
RKDA Stock Slides As Traders Weigh Cash Runway And Charts - timothysykes.com
Arcadia Biosciences (RKDA) Rallies +27.91% as Bulls Target $1.29 2026-05-20Technical Analysis - newsline.com
Arcadia Biosciences (RKDA) Q3 2025 Beat: Revenue $N/A, EPS Exceeds by SignificantDividend Growth Analysis - The Legal Advocate
Armistice Capital (RKDA) reports 159,390 shares, 7.75% stake - Stock Titan
Arcadia Biosciences (RKDA) Delivers Q3 2025 Beat — EPS $0.62 vs $-0.55 ExpectedRevenue Guidance - newser.com
Arcadia Biosciences: Q1 Earnings Snapshot - KTVB
Arcadia Biosciences (RKDA) Announces First Quarter 2026 Financial Results and Business Highlights - The Manila Times
RKDA: Zola volumes rose 18% but net loss widened to $4.4M on lower revenue and one-time charges - TradingView
Arcadia Biosciences | 10-Q: Q1 2026 Earnings Report - Moomoo
Arcadia Biosciences (RKDA) Q1 2026 loss deepens amid going concern risk - Stock Titan
Arcadia Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[8-K] Arcadia Biosciences, Inc. Reports Material Event - Stock Titan
Arcadia Biosciences stock (US03020Q1058): Recent price volatility draws attention - AD HOC NEWS
TradingKey - TradingKey
Resistant Starch Market is expected to Hit US$ 22.3 billion - openPR.com
Why Arcadia Biosciences (RKDA) financial health is stronger than most think (Smart Money Exits) 2026-05-10Popular Market Picks - newser.com
RKDA - Finviz
RKDA Q1'26 Earnings: EPS estimate is (0.80) USD - TradingView
0.17%
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):